Get a firsthand look at the inner workings of our plant in León, Spain, where innovation and attention to detail converge to shape the future of biopharmaceuticals. 💊 🏭 Our Genhelix facilities are equipped with large-scale, single-use bioreactor technology to develop medications efficiently minimizing cross contamination and adapt to our clients’ manufacturing needs. Ready to explore? Follow us for the latest insights from the biopharmaceutical sector! Learn more ➡️ https://lnkd.in/dT7qKnDs #Biopharmaceuticals #Innovation #Genhelix #mAbxience #withinmAbxience #BehindTheScenes #PharmaManufacturing #QualityExcellence
mAbxience
Investigación biotecnológica
Madrid, Madrid 67.654 seguidores
From lab to life
Sobre nosotros
mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South America, have obtained GMP approval from esteemed regulatory bodies, including the FDA, EMA, and others. Furthermore, as a global biopharmaceutical expert, mAbxience specializes in Contract Development and Manufacturing Organization services (CDMO), utilizing advanced technology and innovative platforms to deliver integrated manufacturing solutions. For more insights into mAbxience, our biosimilars and CDMO business, please visit our website (www.mabxience.com)
- Sitio web
-
http://www.mabxience.com
Enlace externo para mAbxience
- Sector
- Investigación biotecnológica
- Tamaño de la empresa
- De 1.001 a 5.000 empleados
- Sede
- Madrid, Madrid
- Tipo
- De financiación privada
- Fundación
- 2009
- Especialidades
- Biosimilars, Hematology, Autoinmune diseases, Oncology, Biotech, Biotechnology, CDMO y CMO
Ubicaciones
Empleados en mAbxience
-
Ignacio (Nacho) Ponce
Global CFO and Corporate Development at INSUDPHARMA GROUP (Chemo, Exeltis, Mabxience, Xiromed BUs) // @nachoponceg
-
Silvana Di Cesare
Business development professional - biopharma contract manufacturing
-
Jurgen Van Broeck
Building partnerships in biopharma/cdmo at mAbxience and healthcare entrepreneur
-
Ana Margarida Almeida
Analytical Development Scientist at mabxience
Actualizaciones
-
At mAbxience, quality and safety are at the core of everything we do. Our latest blog post explores the critical role of Good Manufacturing Practices (GMP) in ensuring that our biopharmaceutical products meet the highest standards of excellence. ✨ 🔍Learn about our state-of-the-art facilities, our adherence to stringent quality controls, and how these practices ensure the safety and efficacy of our products. 🔗Read the full blog post here and see how we continue to set the standard in biopharma production: https://lnkd.in/dGhyDazv #GMP #Biopharma #Quality #mAbxience #Biotech #CDMO
-
-
🌟 Meet Victoria Alejandra Maya Guía, our dedicated Quality Control Analyst at mAbxience. 🌟 Victoria shares her insights on the importance of the attention to detail they meticulously provide at the QC department, to ensure “constant improvement and delivery of the best products and services.” She also shares her experience on the growth opportunities within mAbxience and the trainings designed to deepen our team’s understanding of every process and their final impact in society. 💡 Don’t miss out on “Within mAbxience”, our new video series where we delve into the inner workings of our company and share the experiences of our exceptional team. #mAbxience #WithinmAbxience #CDMO #QualityControl #TeamSpotlight #Excellence
-
🌟 What does it mean to grow with mAbxience? 🌟 In our latest blog post, we dive into the personal stories of three of our dedicated team members— Raúl González Turienzo, Blanca César Caballero, and Marcos Salemi. Each of them has experienced incredible growth and opportunity during their time with us, and their journeys reflect the supportive and dynamic culture we pride ourselves on. Curious to learn more about what it’s like to be part of the mAbxience family? You won’t want to miss these inspiring stories! 🔗 Read the full blog post here and discover how our team thrives together: https://lnkd.in/dS42ZnjK Ready to embark on your own journey with us? Explore our current job openings and see how you can be part of the mAbxience team: https://lnkd.in/d3KCA77c #EmployeeJourney #Growth #TeamCulture #withinmAbxience #Biopharma #CDMO
-
-
At mAbxience, we provide end-to-end services in the B2B biopharmaceutical space, working closely with our partners to deliver world-class solutions globally. 🌍 Our commitment to quality and meticulous attention to detail ensure excellence in every project. With a robust network of partners, we have access to markets across the globe, making a meaningful impact on global health.🌟 🔗Partner with us and experience unparalleled biopharmaceutical expertise: https://lnkd.in/dc9RABui #mAbxience #Biopharma #GlobalHealth #Quality #Biosimilars #MammalianCDMO #EndToEndCDMO #GlobalMarketAccess
-
-
Today, on World Lung Cancer Day, we come together to support the millions affected by this disease. 💙🫁 At mAbxience, our commitment to providing affordable, high-quality treatments drives everything we do. We are dedicated to advancing healthcare in oncology and supporting patients every step of the way. 🔬 #LungCancerAwareness #LungCancerDay #CancerResearch #mAbxience #HopeInHealthcare #Oncology #AccessibleTreatments
-
-
Discover how mAbxience is revolutionizing biopharmaceutical manufacturing with state-of-the-art single-use systems and adaptable processes! 📰 In our latest blog, we delve into how our cutting-edge technologies, like single-use bioreactors, are transforming the industry. We also explore our flexible and scalable manufacturing solutions and our proven expertise in biosimilars and biopharma development. Learn how we're driving excellence in the biotech industry by delivering high-quality, efficient, and safe biopharmaceutical products to the market. Our commitment to innovation ensures we meet and exceed our partners' expectations, making a significant impact on global healthcare. 🔗 Read more about our innovative approach and success stories here Join us in shaping the future of biopharma! 🚀 https://lnkd.in/dFPRc-6j #Biopharma #Innovation #Biotech #SingleUseTechnology #Biosimilars #CDMO #mAbxience
-
-
Kicked off our exciting partnership with Teva Pharmaceuticals in Madrid! We had a fantastic meeting with a group of outstanding individuals who share our commitment to expanding access to essential medicines and healthcare solutions for patients worldwide. Building strong working relationships between our key functions and support teams is crucial for the success of our collaborative efforts. What better way to bond than with rooftop tapas in the heart of Madrid? A huge thank you to the Teva team for their enthusiasm and collaboration. We look forward to a bright future together! Angus Grant, PhD Susie Freda Alex Nesbitt Jose Ramon Millan Niccolò Ciuffi #Partnership #Healthcare #Biosimilars #Teamwork #mAbxience #Teva
-
-
mAbxience ha compartido esto
🌍 Did you know that our biopharmaceutical manufacturing plant in Garín, Argentina, is a regional leader with up to 24,000L mammalian cell culture capacity and two segregated lines? 🧬 💉Our BDS facility produced over 200 million doses of AstraZeneca’s adenoviral vaccine in less than a year. 🔬 Our R&D center features a small-scale facility dedicated to process improvements and new technologies. 🌟 Endorsed by GMP approval from regulatory agencies such as EMA, COFEPRIS, ANMAT, and INVIMA, we are committed to take every product from good to great. Follow us for the latest news and innovations from the biopharmaceutical world! Learn more about our plant in Argentina: https://lnkd.in/dRnVuya3 #withinmAbxience #Biopharmaceuticals #Innovation #BiomanufacturingPlant
-
🌍 Did you know that our biopharmaceutical manufacturing plant in Garín, Argentina, is a regional leader with up to 24,000L mammalian cell culture capacity and two segregated lines? 🧬 💉Our BDS facility produced over 200 million doses of AstraZeneca’s adenoviral vaccine in less than a year. 🔬 Our R&D center features a small-scale facility dedicated to process improvements and new technologies. 🌟 Endorsed by GMP approval from regulatory agencies such as EMA, COFEPRIS, ANMAT, and INVIMA, we are committed to take every product from good to great. Follow us for the latest news and innovations from the biopharmaceutical world! Learn more about our plant in Argentina: https://lnkd.in/dRnVuya3 #withinmAbxience #Biopharmaceuticals #Innovation #BiomanufacturingPlant